278 related articles for article (PubMed ID: 2196078)
1. Side-effects of psoralen photochemotherapy (PUVA).
Wolff K
Br J Dermatol; 1990 Jun; 122 Suppl 36():117-25. PubMed ID: 2196078
[TBL] [Abstract][Full Text] [Related]
2. Minimising the risks of PUVA treatment.
van Praag MC; Tseng LN; Mommaas AM; Boom BW; Vermeer BJ
Drug Saf; 1993 May; 8(5):340-9. PubMed ID: 8504016
[TBL] [Abstract][Full Text] [Related]
3. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
[TBL] [Abstract][Full Text] [Related]
4. Consensus workshop on the toxic effects of long-term PUVA therapy.
Morison WL; Baughman RD; Day RM; Forbes PD; Hoenigsmann H; Krueger GG; Lebwohl M; Lew R; Naldi L; Parrish JA; Piepkorn M; Stern RS; Weinstein GD; Whitmore SE
Arch Dermatol; 1998 May; 134(5):595-8. PubMed ID: 9606329
[TBL] [Abstract][Full Text] [Related]
5. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
Stern RS
Blood Cells; 1992; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
[TBL] [Abstract][Full Text] [Related]
6. Nonmelanoma skin tumors in long-term photochemotherapy treatment of psoriasis. An 8-year follow-up study.
Tanew A; Hönigsmann H; Ortel B; Zussner C; Wolff K
J Am Acad Dermatol; 1986 Nov; 15(5 Pt 1):960-5. PubMed ID: 3782536
[TBL] [Abstract][Full Text] [Related]
7. Long-term risks of psoralen and UV-A therapy for psoriasis.
Farber EM; Abel EA; Cox AJ
Arch Dermatol; 1983 May; 119(5):426-31. PubMed ID: 6342539
[TBL] [Abstract][Full Text] [Related]
8. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
Stern RS;
J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
[TBL] [Abstract][Full Text] [Related]
9. [Photochemotherapy (PUVA): pro and con].
Wolff K
Hautarzt; 1985 Jan; 36(1):25-33. PubMed ID: 3918959
[TBL] [Abstract][Full Text] [Related]
10. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
Stern RS; Laird N
Cancer; 1994 Jun; 73(11):2759-64. PubMed ID: 8194017
[TBL] [Abstract][Full Text] [Related]
11. Psoralen photochemotherapy.
Gupta AK; Anderson TF
J Am Acad Dermatol; 1987 Nov; 17(5 Pt 1):703-34. PubMed ID: 3316316
[TBL] [Abstract][Full Text] [Related]
12. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
Stern RS; Liebman EJ; Väkevä L
J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
[TBL] [Abstract][Full Text] [Related]
13. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence.
Gasparro FP
Am J Clin Dermatol; 2000; 1(6):337-48. PubMed ID: 11702610
[TBL] [Abstract][Full Text] [Related]
14. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
Stern RS; Nichols KT; Väkevä LH
N Engl J Med; 1997 Apr; 336(15):1041-5. PubMed ID: 9091799
[TBL] [Abstract][Full Text] [Related]
15. The benefits and risks of long-term PUVA photochemotherapy.
Momtaz K; Fitzpatrick TB
Dermatol Clin; 1998 Apr; 16(2):227-34. PubMed ID: 9589196
[TBL] [Abstract][Full Text] [Related]
16. Risk of skin tumors in psoralen- and ultraviolet A-treated patients.
Henseler T; Christophers E
Natl Cancer Inst Monogr; 1984 Dec; 66():217-9. PubMed ID: 6531033
[TBL] [Abstract][Full Text] [Related]
17. Skin tumors in the European PUVA Study. Eight-year follow-up of 1,643 patients treated with PUVA for psoriasis.
Henseler T; Christophers E; Hönigsmann H; Wolff K
J Am Acad Dermatol; 1987 Jan; 16(1 Pt 1):108-16. PubMed ID: 3805379
[TBL] [Abstract][Full Text] [Related]
18. Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?
Lindelöf B
Drug Saf; 1999 Apr; 20(4):289-97. PubMed ID: 10230579
[TBL] [Abstract][Full Text] [Related]
19. PUVA, UVB, psoriasis, and nonmelanoma skin cancer.
Studniberg HM; Weller P
J Am Acad Dermatol; 1993 Dec; 29(6):1013-22. PubMed ID: 8245237
[TBL] [Abstract][Full Text] [Related]
20. Epidermal dystrophy and actinic keratoses in psoriasis patients following oral psoralen photochemotherapy (PUVA). Follow-up study.
Abel EA; Cox AJ; Farber EM
J Am Acad Dermatol; 1982 Sep; 7(3):333-40. PubMed ID: 7130492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
